If someone tries to convince you to buy a stock they usually have a personal agenda to do so. Not because they are concerned about you making money but about convincing you to buy so they can make money. Same is true for those yelling sell.
Recent CRVS News
- Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma • GlobeNewswire Inc. • 09/10/2024 12:30:00 PM
- Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/16/2024 04:15:18 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/06/2024 09:31:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:02:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:01:13 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) • GlobeNewswire Inc. • 08/01/2024 12:30:00 PM
- Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases • GlobeNewswire Inc. • 07/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:44:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:20 PM
- Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference • GlobeNewswire Inc. • 05/30/2024 08:02:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2024 09:19:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 09:16:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:06:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:01:14 PM
- Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/06/2024 08:01:00 PM
- Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024 • GlobeNewswire Inc. • 05/02/2024 08:02:00 PM
- Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering • GlobeNewswire Inc. • 05/02/2024 12:30:00 PM
- Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis • GlobeNewswire Inc. • 04/09/2024 08:01:00 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/19/2024 08:02:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024 • GlobeNewswire Inc. • 03/13/2024 08:02:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM